Sweta Kumar (DVM, ERT) is a Senior Toxicologist in Novotech’s Drug Development Consulting group with more than 15 years of experience in nonclinical safety assessment and drug development. She advises sponsors on nonclinical strategy and regulatory planning, with deep expertise in evidence generation for development decisions.





